性结肠炎中moxibustion的有效性和安全性:系统审查和元分析的协议
Yanzhen Li1, Wen Zhou2, Wenxiao Chen2
1School of Clinical Medicine, Nanchang Medical College, Nanchang, Jiangxi, China.
BMJ open
|March 19, 2024
概括
这一系统性审查综合了关于性结肠炎 (UC) 的moxibustion的证据. 它旨在澄清这种补充疗法的临床疗效和安全性,用于管理UC.
科学领域:
- 胃肠病学 胃肠病学
- 综合医学是一个整体的医学.
- 基于证据的医学基于证据的医学.
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病,由于药物疗效有限,难以管理.
- 催化剂是UC的潜在治疗选择,但其临床有效性和安全性需要严格评估.
研究的目的:
- 对治疗性结肠炎 (UC) 的moxibustion临床疗效和安全性的最新证据进行系统审查和综合.
主要方法:
- 在多个数据库 (科克兰图书馆,PubMed,EMBASE等) 中进行全面的搜索. 将在2023年7月之前进行随机对照试验 (RCT).
- 临床疗效,血清炎症因子,结肠镜检查结果,生活质量,复发率和不良事件将被评估为主要和次要结局.
- 将使用Cochrane风险偏差2.0工具评估方法质量,使用RevMan V.5.4分析数据,并通过Cochran的Q和I2测试评估异质性. 将使用GRADE系统来对证据的强度进行分级.
主要成果:
- 数据提取和分析正在等待系统审查过程的完成.
- 该审查将量化moxibustion在改善UC临床结果和患者报告的措施中的有效性.
- 包括不良事件在内的安全数据将被批判性地评估,以告知临床实践.
结论:
- 这一系统性审查将全面评估moxibustion在治疗性结肠炎中的有效性和安全性.
- 这些发现将有助于澄清摩克西布施作为UC补充疗法的作用,并指导未来的研究方向.
- 综合证据将有助于临床医生和患者做出有关UC治疗moxibustion的明智决策.
相关概念视频
01:29Drugs for Treatment of Ulcerative Colitis in IBD
139
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
139
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
434
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
434
01:26Peptic Ulcer Disease IV: Management
91
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
91
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
118
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
118
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
163
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
163